Canada is set to emerge as a key contender in the global race to produce generic versions of Ozempic, the popular diabetes medication, as manufacturers prepare for accelerated approvals and exciting new market opportunities on the horizon
Eli Lilly’s recent launch of Mounjaro in India has sparked a surge in inquiries about weight-loss solutions. The new drug, aimed at managing obesity, has captured significant attention, reflecting a growing demand for effective weight management options in the country.